Not yet recruitingNCT07317453Updated Aug 25, 2026

Precise Image for Musculoskeletal CT

An observational study in Computed Tomography, sponsored by Philips Clinical & Medical Affairs Global. Not yet recruiting. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2026-08-25.

Sponsored by Philips Clinical & Medical Affairs Global (part of Philips) · Observational

Study type: Observational
Model: Other
Time perspective: Retrospective
Enrollment: 84
Ages: 19 Years and older
Sex: All

Study summary

The purpose of this clinical study is to evaluate the performance of the Precise Image reconstruction algorithm for musculoskeletal CT imaging (shoulder, hip, knee) of adult patients (>18 years old). Clinical data generated from this study is intended to support a proposed expansion of the Indications for Use of Precise Image.

The study has two objectives:

To evaluate the image quality and diagnostic acceptability of Precise Image compared to the standard-of-care reference (iDose4) for:
o Musculoskeletal CT images (shoulder, hip, knee) of adult patients (>18 years old).
To demonstrate non-inferiority of Precise Image to iDose4 for the planned resolution groups.

Conditions studied

Computed Tomography

In context

Lead sponsor

Philips Clinical & Medical Affairs Global is the lead sponsor of 85 studies on the registry; 25 are open to participants now.

Of its 15 completed or terminated interventional studies of FDA-regulated products, 12 (80%) have results posted.

Browse Philips Clinical & Medical Affairs Global studies →All Philips studies →

Counted across the registry records on this site, refreshed daily.

Who can participate

Ages eligible: 19 Years and older
Sexes eligible: All
Accepts healthy volunteers: No
Sampling method: Probability sample

Study population

Adults

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Subjects scanned by FDA-cleared and marketed Philips Incisive CT or CT 5300 systems, and according to the department standard of care clinical protocols for the applicable anatomies.
Subject age: Above 18 years old.

Exclusion criteria

Exclusion Criteria:

Subject age: 18 years old and below.
Scans that were acquired using generic 'Body' scan type (as Precise Image does not support generic 'Body' scan types).
Scans that were acquired using a kilovoltage peak of 70 kVp (as Precise Image does not support a kilovoltage peak lower than 80 kVp).
Scans that the site radiologists have deemed as non-diagnostic image quality in standard practice (e.g. patient movement).
Scans that failed internal technical checks (e.g., corrupt files, failure to reconstruct).

Study design

Observational model: Other
Time perspective: Retrospective
Enrollment: 84 participants (estimated)
Patient registry: No

What researchers measure

Primary outcomes

Assessment of CT Image quality and diagnostic confidence of Precise Image via 5-point Likert Scale
The image quality and diagnostic acceptability of Precise Image reconstructions are at least as good as (non-inferior to) iDose4 reconstructions for musculoskeletal CT images (shoulder, hip, knee) of adult patients (\>18 years old). Measurement will be done via 5-point Likert Scale for Image Quality where 5 is excellent and 1 is poor image quality.
Time frame: Reading session at 4 months

Study locations

No study locations are listed for this record.

Timeline

Tracking since Sep 25, 2026

ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jan 2027; primary completion for Jun 2027, 4 months later.

How these figures are worked out, and which studies are left out of them.

Registered: Sep 23, 2025
First posted: Jan 5, 2026
StartEst.: Jan 31, 2027
Primary completionEst.: Jun 1, 2027
CompletionEst.: Dec 1, 2027
Last update: Aug 25, 2026

What these dates mean

Start.: When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.: When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.: When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.: Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.

No changes since tracking began. The registry record was last updated on Aug 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗

Registry details

Key details

Study ID: NCT07317453
Lead sponsor: Philips Clinical & Medical Affairs Global
Collaborators: Philips Healthcare (Suzhou) Co., Ltd.
Responsible party: Sponsor
First posted: Jan 5, 2026
Start date: Jan 31, 2027 (estimated)
Primary completion: Jun 1, 2027 (estimated)
Completion: Dec 1, 2027 (estimated)
Last update: Aug 25, 2026

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Philips Clinical & Medical Affairs Global →

Start the discussion